Abstract
D&MD's Organic and Medicinal Chemistry in Drug Discovery Report analyzes the
methods and technologies currently used to craft compound collections as well
as the products and services available in support of pharma's chemistry
programs. This Report critically evaluates both existing and emerging
technologies for organic synthesis and compound design. In addition, the
technology and market trends in organic and medicinal chemistry for drug
discovery are discussed in depth, and current sales and market projections for
outsourcing products and services are also provided. This Report offers the
views of key industry participants on the state of and future prospects for
organic and medicinal chemistry in drug discovery. This data was obtained
through a proprietary market survey conducted by D&MD publications In addition
to the survey, in-depth interviews were conducted with chemists and managers
in pharma, biopharma, and vendor organizations. The inclusion of the history
and evolution of organic and medicinal chemistry in pharma provides
perspective on current approaches and future directions